Humana (HUM) Reiterated at Neutral by Cantor Fitzgerald on $30B RFP Medicaid Award
Tweet Send to a Friend
Cantor Fitzgerald analyst Sarah James reiterated a Neutral rating and $100.00 price target on Humana (NYSE: HUM).The analyst commented, "IL ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
